Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Allarity Therapeutics, Inc. - Common stock (NQ:ALLR)

0.8301 -0.0563 (-6.35%)
Streaming Delayed Price Updated: 3:43 PM EST, Feb 4, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Allarity Therapeutics, Inc. - Common stock

< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
News headline image
Allarity Granted Hearing Before Nasdaq Panel to Present Plan of Regaining Compliance
From Allarity Therapeutics, Inc.
Via GlobeNewswire
News headline image
Allarity Therapeutics’ Dual PARP/Tankyrase Inhibitor, Stenoparib, Continues to Show Extended Clinical Benefit in Advanced Ovarian Cancer
From Allarity Therapeutics, Inc.
Via GlobeNewswire
News headline image
Why Allarity Therapeutics (ALLR) Stock Is Getting Hammered ↗
Allarity Therapeutics shares are trading lower by 27.6% during Monday's session. The company announced that it received a noncompliance letter from the Nasdaq. 
Via Benzinga
News headline image
Dow Jumps 300 Points; Alimera Sciences Shares Spike Higher ↗
 
Via Benzinga
Topics Stocks
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗
It's time to dive into the biggest pre-market stock movers as we check out all of the hottest news on Monday morning! 
Via InvestorPlace
News headline image
Allarity Therapeutics Regains Compliance with Nasdaq's Minimum Stockholders' Equity Requirement
From Allarity Therapeutics, Inc.
Via GlobeNewswire
News headline image
ALLR Stock Earnings: Allarity Therapeutics Reported Results for Q1 2024 ↗
Allarity Therapeutics just reported results for the first quarter of 2024. 
Via InvestorPlace
News headline image
Allarity Therapeutics Reports First Quarter Financial Results and Highlights, including Clear Clinical Benefits from Phase 2 Trial, NASDAQ Compliance, and Significant Improvement in Cash and Equity Balances
From Allarity Therapeutics, Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
 
Via Benzinga
News headline image
Allarity Therapeutics Announces that All Series A Preferred and All Variable Priced Warrants have Converted to Common Stock
From Allarity Therapeutics, Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Allarity Therapeutics Exceeds Nasdaq’s Minimum Equity Requirement; Requests Voluntarily Withdrawal of Form S-1
From Allarity Therapeutics, Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
 
Via Benzinga
News headline image
Why Is Nano-Cap Allarity Therapeutics Stock Trading Up On Thursday? ↗
Allarity Therapeutics halts Phase 2 trial, citing compelling early results and plans for regulatory advancement. CEO Thomas Jensen affirms strategic shift. ALLR shares surge 38%. 
Via Benzinga
News headline image
JPMorgan Just Raised Its Price Target on Carvana (CVNA) Stock ↗
Carvana stock is climbing higher on Thursday after shares of CVNA got an increased price target and upgrade from JPMorgan analyst Rajat Gupta. 
Via InvestorPlace
News headline image
Emergent BioSolutions Layoffs 2024: What to Know About the Latest EBS Job Cuts ↗
Emergent BioSolutions layoffs have the life sciences company cutting 300 jobs as it also plans to close down two of its facilities. 
Via InvestorPlace
Topics Workforce
News headline image
Why Is Allarity Therapeutics (ALLR) Stock Up 39% Today? ↗
Allarity Therapeutics stock is rising higher on Thursday as investors in ALLR celebrate the company ending a clinical trial early. 
Via InvestorPlace
News headline image
Nasdaq Jumps Over 100 Points; Kellanova Posts Upbeat Results ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Allarity Therapeutics’ Stenoparib Shows Clear Clinical Benefit and Achieves Significant Milestone with Early Conclusion of Phase 2 Trial in Advanced Ovarian Cancer
From Allarity Therapeutics, Inc.
Via GlobeNewswire
News headline image
Allarity Therapeutics Regains Compliance with NASDAQ Minimum Bid Price Requirement
From Allarity Therapeutics, Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
 
Via Benzinga
News headline image
Allarity Therapeutics Receives NASDAQ-Approved Extension to Regain Compliance with Nasdaq Listing Rule 5550(b)(1)
From Allarity Therapeutics, Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗
We are starting the trading week with a dive into the biggest pre-market stock movers worth keeping tabs on for Monday morning! 
Via InvestorPlace
News headline image
Why Medical Properties Trust Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket ↗
Shares of Medical Properties Trust, Inc. (NYSE: MPW) rose sharply in today’s pre-market trading after the company announced that it sold its majority interest in Utah Hospitals. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
 
Via Benzinga
News headline image
Why JPMorgan Shares Are Trading Lower By Around 5%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗
Shares of JPMorgan Chase & Co. (NYSE: JPM) fell sharply during Friday’s session following first-quarter earnings. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.